HER-2/neu Assessment in Breast Cancer by Immunohistochemistry and Fluorescence In Situ Hybridization: Comparison of Results and Correlation With Survival

被引：0
|
作者：
Sanjay Kakar
Nick Puangsuvan
Jane M. Stevens
Romualda Serenas
George Mangan
Shalini Sahai
Michael L. Mihalov
机构：
[1] University of Illinois at Chicago,Department of Pathology
来源：
Molecular Diagnosis | 2000年 / 5卷 / 3期
关键词：
prognosis; Herceptin;
D O I：
10.1007/BF03262077
中图分类号：
学科分类号：
摘要：
Background: HER-2/neu immunohistochemistry (IHC) and fluorescence insitu hybridization (FISH) results guide breast cancer therapy; however, few studies compared the results and no published studies have correlated them with patient outcome.
引用
收藏
页码：199 / 207
页数：8
相关论文
共 50 条
  • [41] Suggestions for HER-2/neu testing in breast carcinoma, based on a comparison of immunohistochemistry and fluorescence in situ hybridisation
    Field, AS
    Chamberlain, NL
    Tran, D
    Morey, AL
    PATHOLOGY, 2001, 33 (03) : 278 - 282
  • [42] Correlation of Her2/Neu testing using chromogenic in situ hybridization (CISH) with immunohistochemistry (IHC) and fluorescence in situ hybridization (FISH) in breast cancer
    Hanna, WM
    Kwok, K
    LABORATORY INVESTIGATION, 2005, 85 : 35A - 35A
  • [43] Correlation of Her2/neu testing using chromogenic in situ hybridization (CISH) with immunohistochemistry (IHC) and fluorescence in situ hybridization (FISH) in breast cancer
    Hanna, WM
    Kwok, K
    MODERN PATHOLOGY, 2005, 18 : 35A - 35A
  • [44] Comparison of immunohistochemical and fluorescence in situ hybridization assessment for topoisomerase IIalpha gene and HER-2/NEU status in breast carcinoma
    Neagu, M.
    Andrei, F.
    Butur, G.
    Diana, T.
    Georgescu, A.
    Ardeleanu, C.
    FEBS JOURNAL, 2008, 275 : 340 - 340
  • [45] Comparison of chromogenic in situ hybridisation with fluorescence in situ hybridisation and immunohistochemistry for the assessment of Her-2/neu oncogene in archival material of breast carcinoma
    Pothos, Alexios
    Plastira, Konstantina
    Plastiras, Aris
    Vlachodimitropoulos, Dimitrios
    Goutas, Nikolaos
    Angelopoulou, Roxani
    ACTA HISTOCHEMICA ET CYTOCHEMICA, 2008, 41 (03) : 59 - 64
  • [46] Evaluation of Genetic Status of HER-2/neu and Aneusomy 17 by Fluorescence In Situ Hybridization and Comparison with Immunohistochemistry Assay from Indian Breast Cancer Patients
    Kokate, Prajakta
    Sawaimoon, Satyakam
    Bhatia, Simi
    Mandava, Swarna
    GENETIC TESTING AND MOLECULAR BIOMARKERS, 2012, 16 (04) : 239 - 245
  • [47] HER-2/neu gene copy quantified by real-time PCR and serum HER-2/neu by Elisa assay: comparison with fluorescence in situ hybridization and immunohistochemistry
    Tse, C.
    Brault, D.
    Gligorov, J.
    Antoine, M.
    Lelay, K.
    Lotz, J. P.
    EJC SUPPLEMENTS, 2004, 2 (03): : 171 - 171
  • [48] Laboratory assessment of the status of Her-2/neu protein and oncogene in breast cancer specimens: comparison of immunohistochemistry assay with fluorescence in situ hybridisation assays
    Wang, S
    Saboorian, MH
    Frenkel, E
    Hynan, L
    Gokaslan, ST
    Ashfaq, R
    JOURNAL OF CLINICAL PATHOLOGY, 2000, 53 (05) : 374 - 381
  • [49] Comparison of fluorescence in situ hybridization and immunohistochemical analysis for HER-2/neu detection in breast carcinoma.
    Li, Y
    Battaglia, T
    Davis, M
    Hankins, L
    Hagemeister, S
    Arthur, T
    Tawfik, O
    Persons, D
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2002, 118 (04) : 641 - 642
  • [50] IMMUNOHISTOCHEMICAL HER-2/NEU EXPRESSION WITH GENE AMPLIFICATION BY FLUORESCENCE IN SITU HYBRIDIZATION FOR ASSESSMENT IN BREAST CARCINOMAS
    Moatter, Tariq
    Zeeshan-ud-din
    Khilji, Zahida Latif
    Murad, Farzana
    Kayani, Naila
    Pervez, Shahid
    JCPSP-JOURNAL OF THE COLLEGE OF PHYSICIANS AND SURGEONS PAKISTAN, 2007, 17 (12): : 726 - 730
12345